No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DRCT Direct Digital
- 5.835
- -0.285-4.66%
Trading Apr 26 13:04 ET
83.71MMarket Cap44.88P/E (TTM)
6.353High5.724Low63.97KVolume6.110Open6.120Pre Close381.96KTurnover2.12%Turnover Ratio44.88P/E (Static)14.35MShares35.88452wk High36.02P/B17.62MFloat Cap1.96052wk Low--Dividend TTM3.02MShs Float35.884Historical High--Div YieldTTM10.28%Amplitude1.160Historical Low5.970Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Communication Services Stocks Moving In Wednesday's Intraday Session
GainersChicken Soup for the Soul (NASDAQ:CSSE) stock moved upwards by 140.2% to $0.37 during Wednesday's regular session. The company's market cap stands at $11.8 million. As per the press release, Q4
The Analyst Verdict: Direct Digital Holdings In The Eyes Of 5 Experts
In the last three months, 5 analysts have published ratings on Direct Digital Holdings (NASDAQ:DRCT), offering a diverse range of perspectives from bullish to bearish.The table below offers a condense
Direct Digital Price Target Maintained With a $23.00/Share by Benchmark
Direct Digital Price Target Maintained With a $23.00/Share by Benchmark
Direct Digital Holdings: Strong Revenue Collection and Proactive Compliance Measures Affirm Buy Rating
Benchmark Reiterates Buy on Direct Digital Holdings, Maintains $23 Price Target
Benchmark analyst Daniel Kurnos reiterates Direct Digital Holdings (NASDAQ:DRCT) with a Buy and maintains $23 price target.
Direct Digital Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/24/2024 275.82% Benchmark → $23 Reiterates Buy → Buy 03/27/2024 210.46% Roth MKM $27.5 → $19 Maintains
Comments
$iBio Inc (IBIO.US)$ IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for obesity and cardiometabolic diseases.
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
0% 
$Direct Digital(DRCT.US$ 👀 top of the month
Direct Digital Holdings' positive reinvestment and profitability, along with a 566% stock return over the past year, suggest a promising future. However, high current liabilities could pose a concern.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg